Press release
Brucellosis Vaccines Market Set to Double by 2033 Amid Rising Zoonotic Threats
Brucellosis Vaccines Market
The global brucellosis vaccines market, valued at $0.2 billion in 2023, is projected to reach $0.4 billion by 2033, growing at a CAGR of 6.4% from 2024 to 2033. This growth is driven by the increasing burden of brucellosis in livestock, heightened zoonotic disease awareness, and rising government investment in veterinary healthcare infrastructure.
Market Overview
Brucellosis, caused by bacteria of the Brucella genus, remains a major threat to livestock industries across the globe. The disease leads to reproductive issues in animals and poses public health risks due to its zoonotic nature-transmitting from animals to humans through unpasteurized dairy products or direct contact.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A324385
Key Highlights:
Affects cattle, sheep, goats, and occasionally pigs and dogs.
Human brucellosis causes fever, joint pain, and fatigue, with long-term complications if untreated.
Vaccination is the frontline defense in managing outbreaks, especially in high-density livestock zones.
Key Market Drivers
📈 Rising Disease Prevalence
Brucellosis affects 1.3% of individual animals and 11% of herds, per the National Library of Medicine (2022).
🏛️ Government Support
Countries like the UK have launched multi-million-dollar grants for vaccine development and disease control.
🐄 Growing Livestock Populations
Global cattle numbers rose from 929.56M in 2020 to 943.74M in 2023, increasing the need for brucellosis immunization.
💉 Advancements in Vaccine Technology
Innovations like DNA and recombinant vaccines are enhancing immunization effectiveness and safety profiles.
Market Segmentation
By Vaccine Type
RB51 - Preferred for cattle, especially in North America
S19 - Widely used live attenuated vaccine
B19 - Commonly used for small ruminants like goats and sheep
By Technology
DNA Vaccines
Subunit Vaccines
Vector Vaccines
Recombinant Vaccines
By Animal Type
Cattle (dominant due to economic implications)
Sheep & Goats
By End User
Veterinary Clinics & Hospitals
Animal Care Centers
Research Institutes & Government Agencies
Regional Insights
Region 2023 Market Share Growth Trend
North America Highest share Driven by R&D and regulation
Europe Strong adoption Moderate but steady
Asia-Pacific Fastest-growing Huge livestock base
LAMEA Emerging potential Gradual expansion
Country-Level Trends
🇺🇸 United States: With 91.9 million cattle, vaccine demand is strong.
🇮🇳 India: Home to 535.7 million farm animals; active government vaccination programs underway.
🇨🇳 China & 🇧🇷 Brazil: Rapid livestock sector growth is increasing vaccine penetration.
Industry Trends & Developments
🧬 University of Florida (2022): Created a vaccine offering long-term immunity for small ruminants.
🌏 Ceva Santé Animale: Expanded into Japan with Mitsui & Co., targeting Asian market opportunities.
🦠 CDC (2023): Estimates 2.1 million global brucellosis cases annually, underlining the public health concern.
Key Players
Ceva Santé Animale
Merck & Co., Inc.
Indian Immunologicals Ltd.
Hester Biosciences Ltd.
Colorado Serum Company
Recent Developments
🔬 Dec 2022: Breakthrough in long-term brucellosis vaccines for small ruminants.
🌐 Apr 2022: Ceva's expansion into Japan boosts its global footprint.
Future Outlook (2024-2033)
🚜 Rising livestock numbers will drive consistent vaccine uptake.
💸 Government funding and policies will play a pivotal role in rural immunization campaigns.
🔧 Biotechnological innovation will push next-gen vaccines into mainstream use.
Key Takeaways
✔️ Brucellosis vaccine market to double in value by 2033.
✔️ Asia-Pacific to lead growth, fueled by large animal populations.
✔️ RB51 and S19 remain the most preferred vaccines.
✔️ Increased zoonotic disease vigilance will shape regulatory priorities.
Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/A324385
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Brucellosis Vaccines Market Set to Double by 2033 Amid Rising Zoonotic Threats here
News-ID: 4018519 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
